CHS Press Release
These medications can be administered at any time of day, with or without meals, on the same day each week
Understanding how to administer retatrutide correctly is essential for anyone participating in a clinical trial involving this medicine
You may be a good candidate if: You have a BMI of 27 or higher You struggle with cravings or portion control You've tried diet and exercise with limited success You dont have contraindications such as certain thyroid conditions or pancreatitis Avere Beauty will conduct a full medical screening before starting treatment
Orforglipron (Eli Lilly): The Oral Option Eli Lilly is also developing orforglipron, an oral (pill) GLP-1 agonist
Required documentation for PA: Complete medical history and physical exam notes Current height, weight, BMI calculation List of weight-related comorbidities with diagnostic codes Lab results (A1C, lipid panel, metabolic panel) Documentation of lifestyle intervention attempts and outcomes Letter of medical necessity from prescribing provider Confirmation of no contraindications Common reasons for PA denial: BMI doesn't meet plan threshold (patient has BMI 27-29.9, plan requires 30+) Insufficient documentation of lifestyle intervention failure Missing required lab work Presence of contraindication (history of pancreatitis, family history of medullary thyroid cancer) Medication not on plan formulary If your PA is denied, you have the right to appeal